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Abstract The histone acetyltransferase (HAT) Mof is essential for mouse embryonic stem cell 
(mESC) pluripotency and early development. Mof is the enzymatic subunit of two different HAT 
complexes, MSL and NSL. The individual contribution of MSL and NSL to transcription regulation in 
mESCs is not well understood. Our genome-wide analysis show that i) MSL and NSL bind to specific 
and common sets of expressed genes, ii) NSL binds exclusively at promoters, iii) while MSL binds in 
gene bodies. Nsl1 regulates proliferation and cellular homeostasis of mESCs. MSL is the main HAT 
acetylating H4K16 in mESCs, is enriched at many mESC-specific and bivalent genes. MSL is 
important to keep a subset of bivalent genes silent in mESCs, while developmental genes require 
MSL for expression during differentiation. Thus, NSL and MSL HAT complexes differentially regulate 
specific sets of expressed genes in mESCs and during differentiation.
DOI: 10.7554/eLife.02104.001
Introduction
Pluripotent mouse embryonic stem cells (mESCs) have the ability to self-renew or to differentiate into 
all cell types. Specific transcription factors like Oct4, Sox2, and Nanog form a core transcriptional net-
work, which is required for the maintenance of mESC pluripotency (Orkin et al., 2008). Chromatin-
modifying enzymes further regulate transcriptional mESCs networks and cellular differentiation 
processes and can be associated with activation or repression of genes (Orkin and Hochedlinger, 
2011). Histone acetylation is important for mESC pluripotency and is regulated by the concerted 
action of histone acetyltransferases (HATs) and histone deacetylases (HDACs) (Meshorer and 
Misteli, 2006). Acetylation of histone proteins leads to an open and dynamic chromatin conformation 
allowing an active transcription state, which is also a signature of mESC pluripotency (Meshorer, 
2007; Niwa, 2007; Efroni et al., 2008). During differentiation of mESCs, the overall transcription 
rates decrease, whereas the chromatin structure becomes more compact with a global reduction of 
histone H3 and H4 acetylation. In line with the requirement of histone acetylation in mESC mainte-
nance and differentiation, genetic deletion or knockdown of several HATs affects mESC pluripotency 
(Lin et al., 2007; Fazzio et al., 2008; Gupta et al., 2008; Thomas et al., 2008; Zhong and Jin, 2009; 
Li et al., 2012).
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HATs can be classified into two predominant families: the GCN5-related N-acetyltransferase (GNAT) 
family (i.e. Gcn5 and p300) and the Moz-Ybf2/Sas3-Sas2-Tip60 (MYST) family (i.e., Tip60 and Mof 
[male absent on the first]) (reviewed in Kimura et al., 2005). These enzymes often function as part of 
multi-protein co-activator complexes (reviewed in Lee and Workman, 2007). Mof (also known as Kat8 
or Myst1), is a MYST-type HAT specific for histone H4 lysine 16 acetylation (H4K16ac) (Hilfiker et al., 
1997; Smith et al., 2001, 2005; Taipale et al., 2005) and has been shown to be the catalytic subunit 
of two distinct protein complexes in Drosophila (d) and mammals: the male-specific lethal (MSL) and 
the non-specific lethal (NSL) complexes (Smith et al., 2005; Mendjan et al., 2006; Cai et al., 2010; 
Raja et al., 2010). In Drosophila, the dMSL complex is targeted to transcribed regions of male 
X-chromosomal genes, where it mediates dosage compensation (reviewed in Straub and Becker, 
2007; Gelbart and Kuroda, 2009; Conrad and Akhtar, 2011). In contrast, dNSL is present at gene 
promoters of male and female chromosomes, where it regulates transcription of housekeeping genes 
(Prestel et al., 2010; Raja et al., 2010; Feller et al., 2012; Lam et al., 2012). Mof itself and subunits 
of the Mof-containing dMSL and dNSL HAT complexes are required for the binding of the two 
Drosophila Mof-containing complexes at promoters and gene bodies, which leads to H4K16 acetyla-
tion and gene expression (Raja et al., 2010; Kadlec et al., 2011).
Inactivation of Mof in mice (m) leads to early embryonic lethality as Mof−/− embryos fail to develop 
beyond the expanded blastocyst stage and die at implantation (Gupta et al., 2008; Thomas et al., 
2008). Mof deletion correlated with cell cycle defects and cell death. Moreover, mESCs could not be 
derived from Mof−/− mouse embryos. In agreement, it was shown that Mof plays an essential role in the 
maintenance of mESC pluripotency (Li et al., 2012). H4K16 acetylation levels were undetectable in 
Mof−/− embryos, whereas the acetylation of other histone lysine residues was unaffected (Thomas 
et al., 2008). Surprisingly, loss of H4K16 acetylation upon neuronal differentiation of mESCs did not 
alter higher-order chromatin compaction (Taylor et al., 2013). Moreover H4K16ac and Mof were 
reported to be present at the transcription start sites (TSSs) of expressed genes in mESCs (Li et al., 
2012; Taylor et al., 2013).
eLife digest Embryonic stem cells are special cells that have the ability to become many 
different types of cells, such as skin, muscle, or neuronal cells. This process is called differentiation. 
They can also undergo a process called self-renewal to produce more embryonic stem cells. These 
processes are controlled by a complex network of enzymes, and the production of these enzymes 
depends on various genes within the organism being expressed as proteins.
The DNA that holds the genetic information inside cells spends most of its time wrapped around 
proteins called histones: this allows the DNA molecules—which can be up to several metres long in 
some species—to fit inside the cell nucleus; it also protects the DNA molecules, which are quite 
fragile, from damage. Enzymes that attach chemical groups called acetyl groups to histones have a 
central role in controlling the self-renewal and differentiation of embryonic stem cells.
Mof is an enzyme that attaches an acetyl group to a specific position in a particular histone. It  
is a subunit within two larger protein complexes that were originally identified in flies: the male-
specific lethal (MSL) complex, which is only found in male flies, and the non-specific lethal (NSL) 
complex, which is found in both male and female flies. These complexes have been widely studied 
in flies, and the role of the Mof enzyme is also reasonably well understood in mammals. However, 
the roles of the MSL and NSL protein complexes in mammals are not fully understood.
Ravens et al. have now used a combination of a technique called ChIP-seq (which can identify 
binding sites anywhere in the genome) and genetic ‘knock down’ experiments to explore the roles 
of these two complexes in mouse embryonic stem cells and neuronal progenitor cells.
There is some overlap between the genes that the complexes act on. However, NSL acts on 
some genes than MSL does not act on, and vice versa. NSL mostly acts on genes that have 
‘housekeeping’ functions and are expressed in many different cell types. MSL binds more to genes 
that are specific to embryonic stem cells, and acts on genes required for the development of 
neuronal progenitor cells. This means that NSL regulates the growth of embryonic stem cells, 
whereas MSL controls their development and differentiation.
DOI: 10.7554/eLife.02104.002
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Details on the function of the mammalian Mof-containing MSL and NSL complexes have only 
recently started to emerge and revealed that Mof fulfils different functions within the two HAT com-
plexes. Human (h) MSL complex is composed of the subunits MSL1, MSL2, MSL3, and MOF (Smith 
et al., 2005; Mendjan et al., 2006), while the hNSL complex is composed of nine subunits: NSL1, 
NSL2, NSL3, MCRS1, WDR5, PHF20, HCF1, OGT1, and MOF (Mendjan et al., 2006; Cai et al., 2010). 
Mammalian NSL complex appears to have broader substrate specificity than the MSL complex, as it is 
also able to acetylate non-histone targets (Li et al., 2009). However, the function of MSL and NSL 
complexes in mammalian cells and especially their role in establishing mESC pluripotency in not well 
understood.
To better understand the role of MSL and NSL in gene regulation and their individual contribution 
in epigenetic changes in mESCs, we have analysed these two Mof-containing complexes by chromatin 
immunoprecipitation coupled with high throughput sequencing (ChIP-seq) and by shRNA knockdown 
(KD) experiments in mESCs. The obtained genome-wide binding maps show that MSL and NSL locate 
to a large number of expressed genes and each complex has a distinct binding profile at promoters or 
gene bodies. Our combined ChIP-seq and KD data indicate that MSL and NSL have a combinatorial 
effect on a given set of genes, whereas some specific loci are only MSL- or only NSL-dependent. Our 
data indicate that NSL binds exclusively at promoters, while MSL binds more in gene bodies. We show 
that in mESCs NSL regulates cell growth whereas MSL is the main HAT complex acetylating histone 
H4K16. MSL is present at mESC-specific genes. Moreover, MSL binds to and regulates developmental 
genes in mESCs and during differentiation. Altogether our data demonstrate that MSL and NSL com-
plexes are present at expressed genes in mESCs, but that MSL is essential for regulation of key mESC-
specific and bivalent developmental genes.
Results
Both Msl1 or Nsl1 incorporate in their respective Mof-containing HAT 
complexes in mESCs
To understand the global role of the two Mof-containing complexes in chromatin remodelling and how 
this regulates genes linked to self-renewal, proliferation, and/or differentiation, we set out to analyse 
the genome-wide binding of MSL and NSL in mESCs. To this end, we raised antibodies targeting Msl1 
or Nsl1, which are specific subunits of the MSL or NSL complexes, respectively, and are known to play 
a role in the assembly and the regulation of these complexes (Raja et al., 2010; Kadlec et al., 2011). 
The specificity of the purified antibodies was demonstrated by western blot assays and immunopre-
cipitations followed by mass spectrometry using the multidimensional protein identification tech-
nology (MudPIT) (Figure 1). Western blot assays indicated that both of the generated antibodies are 
specific (Figure 1A,B). In addition, both antibodies immunoprecipitated (IP-ed) the endogenous 
MSL and NSL complexes with the previously described polypeptide composition (Cai et al., 2010; 
Figure 1C). Importantly, Mof was identified in both IP-ed MSL or NSL complexes, in the same range 
of abundance than Msl1, or Nsl1 (Figure 1C, Figure 1—source data 1 for all identified proteins by 
MudPIT). Gel filtration followed by western blot analyses further indicated that Msl1 and Nsl1 are only 
present in Mof-containing complexes as they have eluted from the Superose 6 column in the same 
molecular weight containing fractions as their respective entire endogenous MSL (about 240 kDa), or 
NSL (about 800 kDa) complexes (Figure 1D). Of note the enzymatic subunit Mof was detected in the 
respective MSL and NSL complexes, but in addition as a potentially free form in the 50 kDa range frac-
tions (Figure 1D). These results together demonstrate the incorporation of all nuclear Msl1, or Nsl1, 
together with Mof, in their respective endogenous complexes and a fraction of ‘free’ Mof that is not 
present in either MSL or NSL.
MSL binds mainly to gene bodies, while NSL to promoter regions in 
mESCs
To characterize the genome-wide role of MSL and NSL complexes, we carried out ChIP-seq analysis in 
mESCs using the above-characterized anti-Msl1 and anti-Nsl1 antibodies. The obtained binding maps 
of Msl1 and Nsl1 in mESCs were then compared at the UCSC genome browser to publicly available 
ChIP-seq data for Mof, H4K16 acetylation (H4K16ac), RNA Polymerase II (Pol II), and DNAse hypersen-
sitive sites (DHS). At a representative genomic locus, Nsl1 peaks were detected at the TSSs of four 
expressed genes, where they co-localized with Mof, Pol II and DHSs, whereas Msl1 binding peaks were 
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usually broader and together with H4K16ac down-
stream of Pol II peaks (Figure 2A). As previously 
reported, Mof is present at promoters, gene bodies 
(GBs) and intergenic regions (Li et al., 2012).
Using MACS14 algorithm (Zhang et al., 2008) 
we determined high-confidence binding sites 
(peaks) for Msl1 or Nsl1 (Figure 2—figure supple-
ment 1A, Figure 2—source data 1) and selected 
peaks with various tag densities for ChIP-qPCR 
validation. The Msl1 and Nsl1 enrichments at five 
different loci as detected by ChIP-qPCR faithfully 
reflected the tag densities measured by ChIP-seq 
(Figure 2—figure supplement 1B,C). To further 
verify the specificity of the Msl1 and Nsl1 ChIP-
seq results, we used lentiviral small hairpin (sh) 
RNA vectors to knockdown (KD) Msl1 or Nsl1 in 
mESCs (Figure 2—figure supplement 2A–D) 
and tested by ChIP-qPCR the decrease of Msl1 
or Nsl1 binding at the TSSs and in the GBs of 
two genes that were co-bound by these factors 
(Figure 2—figure supplement 2E,D). The pre-
dominant binding of Msl1 to GBs was lost upon 
Msl1 KD, whereas Nsl1 binding to TSS was 
reduced following Nsl1 depletion. These results 
confirm our ChIP-seq analyses.
Next, we asked whether the two complexes 
bind to common or different loci. A pairwise com-
parison of the MSL or NSL enrichment at all high 
confidence binding loci revealed that the binding 
of both complexes show two populations and 
have a Pearson correlation coefficient of 0.23 
(p-value=1.88 × 10−160) (Figure 2B). This indicates 
a significant overlap between Msl1 and Nsl1 
binding populations, but suggests also a differen-
tial genome-wide binding of MSL and NSL. To 
know at which genomic regions the identified 
peaks localize, each peak was annotated either to 
promoter, GB (containing introns, exons, untrans-
lated regions and transcription termination sites 
together) or intergenic regions. 74% of all Msl1 
peaks are detected at GBs (Figure 2C). In contrast, 
the majority of identified Nsl1 peaks are present 
at promoter regions (67%) (Figure 2C). Moreover, 
only about 10% of all Msl1- or Nsl1-binding sites 
map to intergenic regions (as defined above, 
excluding introns). The majority of the 9890 Msl1-, 
or 6251 Nsl1-specific binding sites are at pro-
moter and/or GB regions (Figure 2C), and after 
removal of redundant genes, we defined 5844 
Msl1- and 4755 Nsl1-bound genes (Figure 2—
figure supplement 1A, Figure 2—source data 2). 
As only 10% of the binding sites were detected at 
intergenic regions, we focused our further analyses on the role of MSL and NSL complexes in gene 
regulation at the promoter and/or GB regions.
To understand the genome-wide binding of MSL and NSL, we compared by k-means clustering either 
Msl1, or Nsl1 binding profiles with that of Mof and the presence of H4K16ac at 30,300 ENSEMBL 
Figure 1. Msl1 and Nsl1 incorporate into endogenous 
complexes in mESCs. (A and B) Western Blot analysis 
using the raised anti-Msl1 (3208) or anti-Nsl1 (3130) 
antibodies on nuclear extracts. Preimmune sera (pre) 
were used as negative controls. (C) Anti-Msl1 (3208) or 
anti-Nsl1 (3130) antibodies were used to immunopre-
cipitate protein complexes from mESC nuclear extracts. 
The IP-ed complexes were then analysed by multidi-
mensional protein identification technology (MudPIT). 
The identified MSL- or NSL-containing complex proteins 
and their relative protein abundance in the samples are 
represented by normalized spectral abundance factor 
(NSAF) (Zybailov et al., 2006). NSAF allows the 
comparison of abundance of individual proteins in 
multiple independent samples and in multiprotein 
complexes (Florens et al., 2006; Paoletti et al., 2006). 
The colour intensity reflects of the NSAF values 
multiplied by 1000 (as indicated). (D) Gel filtration of 
mESC nuclear extracts. Every second fraction eluted 
from a Superose 6 column was analysed for the 
presence of Nsl1, Msl1, and Mof by Western Blot. 
Molecular weight markers for the corresponding 
fractions are indicated on the top of the panel.
DOI: 10.7554/eLife.02104.003
The following source data are available for figure 1:
Source data 1. List of identified proteins of MudPIT 
analyses. 
DOI: 10.7554/eLife.02104.004
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Figure 2. Distinct binding profiles of Msl1 and Nsl1 at active genes. (A) UCSC genome browser tracks representing 
Msl1, Nsl1, H4K16ac, Mof and Pol II ChIP-seq data. The Input serves as control. (B) Scatter Plot showing the Pearson 
correlation between Msl1 and Nsl1 densities at all identified MACS14 peak regions. Densities were normalized to 
the control (Input) and represented as log2 values. (C) Mapping of Msl1 and Nsl1 identified MACS14 peaks to 
different genomic regions (promoter-TSS, genebody [GB] or intergenic regions) using HOMER (Heinz et al., 2010). 
Identified peaks are listed in Figure 2—figure supplement 1A and Figure 2—source data 1. Validation of 
identified peaks is shown in Figure 2—figure supplement 1B,C. (D) Heatmap showing k-means clustering of Msl1, 
Nsl1, Mof and H4K16ac using the TSSs of all ENSEMBL transcript IDs as reference coordinates. Densities are 
Figure 2. Continued on next page
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transcription start sites (TSSs). In good agreement with our results showing that in mESCs Msl1 
and Nsl1 incorporate in the endogenous MSL or NSL complexes, respectively, genome-wide Mof 
binding overlaps with that of Msl1 and Nsl1 around most of the TSSs, which are also H4K16ac posi-
tive (Figure 2D).
Interestingly, at promoters, MSL and NSL complexes have distinct binding profiles. Nsl1 and Mof 
show a sharp binding peak centred at the TSSs, while the average Msl1 binding profile is similar to 
H4K16ac (see below) and extends downstream from the TSSs in the GB regions (Figure 2E). Moreover, 
the Msl1 and Mof signals are enriched downstream of promoters at GBs, whereas the control and the 
Nsl1 signals are not (Figure 2F). Altogether our results demonstrate that MSL and NSL bind mostly to 
distinct sites in mESCs. NSL binds directly to the TSS region of genes, while the genome-wide location 
of MSL is both at TSSs and downstream of the TSSs of bound genes.
MSL and NSL bind to active genes, but are differently related to gene 
expression
To assess the relationship between Msl1 and Nsl1 binding and gene expression in mESCs, we took 
advantage of available RNA-seq data (Tippmann et al., 2012) and compared the average expres-
sion of Msl1-, or Nsl1-bound genes (in median log2 FPKM values) to that of all ENSEMBL genes 
(Figure 3A). The median expression values for Msl1-, or Nsl1-positive genes were significantly higher 
as compared to all ENSEMBL genes, demonstrating that Msl1 and Nsl1 are mostly present at expressed 
genes in mESCs.
To determine whether the binding strength of Msl1 or Nsl1 correlates with gene expression, we 
compared Msl1 and Nsl1 enrichment around TSSs with gene expression data from the corresponding 
bound genes. Msl1- or Nsl1-positive genes were divided into five categories according to their expres-
sion levels (Figure 3B–D). As a control, in the same five categories densities of Pol II peaks at promot-
ers correlated with gene expression with decreasing Pol II densities from highly to poorly expressed 
genes (Figure 3A; Barski et al., 2007). Importantly, the boxplot representation revealed a similar 
correlation as Pol II between Msl1 binding and gene expression, indicating that the stronger the gene 
is expressed the higher Msl1 and Pol II are enriched at the binding sites (Figure 3B,C). In contrast, 
there is no significant difference of the Nsl1 median values between the five groups, indicating that 
Nsl1-binding to promoters is not proportional with the level of expression (Figure 3D). Our results 
thus demonstrate that both Msl1 and Nsl1 bind to active genes, but that only the binding strength of 
Msl1, and not that of Nsl1, correlates with mRNA levels, suggesting a different dynamic and/or func-
tional behaviour of the two complexes at the regulated loci.
The localization of MSL, but not that of NSL, overlaps with the 
presence of H4K16ac
As H4K16 is a known target of Mof in Drosophila and mammals (Hilfiker et al., 1997; Smith et al., 
2001, 2005; Taipale et al., 2005), we compared Msl1 or Nsl1 binding sites with the presence of 
H4K16ac. Our scatter plot analyses indicate that there is a general overlap of Msl1 or Nsl1 with 
presented ±2 kb around reference coordinates. Input serves as negative control. (E and F) Average binding profiles 
of Msl1, Nsl1 and Mof (E) at a region of +1 kb around the annotated TSSs and (F) 1 kb upstream of the TSS, in the 
GB and 1 kb downstream of the TTS. Only Nsl1 or Msl1 positive genes were taken into consideration. The Input 
serves as control and tag densities were normalized to the input. See Figure 2—figure supplement 2 for 
validation of ChIP-seq data.
DOI: 10.7554/eLife.02104.005
The following source data and figure supplements are available for figure 2:
Source data 1. List of Msl1 and Nsl1 MACS14 peaks. 
DOI: 10.7554/eLife.02104.006
Source data 2. List of Msl1 and Nsl1 positive genes. 
DOI: 10.7554/eLife.02104.007
Figure supplement 1. Identification and validation of Msl1 and Nsl1 binding sites. 
DOI: 10.7554/eLife.02104.008
Figure supplement 2. Knockdown (KD) of Msl1 or Nsl1 through lentiviral shRNA vectors. 
DOI: 10.7554/eLife.02104.009
Figure 2. Continued
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Figure 3. Msl1 and Nsl1 bind to active genes, but participate differentially to gene expression. (A) Boxplots 
showing the log2 of RNA FPKM expression values from mESCs of all analysed, Msl1-, or Nsl1-bound ENSEMBL 
genes. (B, C and D) RNA expression values are ranked into five groups, where group 5 represents the highest RNA 
expression level and group 1 the lowest (see bottom of panels B–D). Boxplots show the tag density of the nearest 
peak to the TSS for (B) Pol II, (C) Msl1 and (D) Nsl1 tag densities around the TSSs at the five groups. Only density 
values higher than zero were taken into consideration. The median is different between groups, if the notches of 
the boxplots do not overlap.
DOI: 10.7554/eLife.02104.010
H4K16ac, whereas the correlation between Msl1 binding sites and H4K16ac is better (Pearson corre-
lation coefficient 0.57) than between Nsl1 and H4K16ac (Pearson correlation coefficient 0.32), which is 
also reflected in the corresponding p-values (Figure 4A,B). The comparison of the distribution pat-
terns of Msl1, Nsl1, Pol II and H4K16ac around the TSSs (±2 kb) of all Msl1- and Nsl1-bound genes 
further indicates that the Msl1 binding profile is more similar to the genome-wide presence of H4K16ac, 
than that of Nsl1 (Figure 4C). H4K16ac levels are enriched downstream of the TSSs overlapping with 
the binding profile of Msl1 (Figure 4C). In contrast, the centre of the Nsl1 binding profile centred at 
the TSS region does not overlap with that of the H4K16ac peak (Figure 4C). These binding profiles 
suggest a link between H4K16 acetylation and the MSL HAT complex (Figure 4).
MSL is the main H4K16 acetylase in mESCs
Although it was demonstrated that Mof depletion in embryos results in a loss of H4K16ac (Gupta 
et al., 2008; Thomas et al., 2008), the exact contribution of the two Mof-containing HAT complexes 
to H4K16 acetylation remains to be determined. To address this question, we analysed the global 
acetylation of H4K16 after Msl1 or Nsl1 KD and also quantified acetylation of H4K5 and H4K8, two 
other proposed substrates for hNSL in differentiated human cells (Cai et al., 2010). Western blot 
analyses of total histone proteins from mESCs expressing shRNAs targeting Msl1 or Nsl1 revealed a 
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Figure 4. MSL affects H4K16 acetylation in mESCs. (A and B) Scatter Plots indicating the Pearson correlation and 
Pearson p-values between H4K16ac and Msl1 (A) or Nsl1 (B) densities at Msl1 peaks or Nsl1 peaks. Log2 represent-
ed tag densities were calculated at peak regions and normalized to the control (Input) data set. (C) Average 
binding profiles of Msl1, Nsl1, Pol II and H4K16ac at a region of +2 kb around all ENSEMBL promoters. Only Nsl1 
and Msl1 positive genes are taken into consideration. The input serves as control and tag densities are normalized 
to the input. (D) mESCs were treated for 5 days with lentiviral vectors expressing sh control, sh Msl1, or sh Nsl1 
interfering RNAs. Total histones were isolated by acidic extraction and H4K16ac, H4K5ac, and H4K8ac levels were 
analysed by western blot. Histones were normalized using an antibody against non-modified histone 3 (H3). KD 
efficiencies were tested in Figure 2—figure supplement 2A–D.
DOI: 10.7554/eLife.02104.011
dramatic reduction of H4K16ac upon Msl1 depletion, whereas Nsl1 KD did not affect H4K16ac levels 
(Figure 4D). This is in good agreement with the differential Msl1 and Nsl1 ChIP-seq profiles (Figure 4C). 
Moreover, H4K5ac and H4K8ac levels did not change in cells expressing either Msl1 or Nsl1 shRNA 
(Figure 4D). Altogether, the above results indicate that in mESCs (i) the enzymatic activity of the MSL 
complex is responsible for H4K16 acetylation downstream of the TSS, (ii) MSL is the main acetylase for 
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H4K16 and (iii) the global H4K16 acetylating function of MSL cannot be compensated by other HAT 
complexes.
MSL is present at genes regulating the pluripotency network and 
developmental processes
To understand the role of the two Mof-containing complexes for gene regulation and regulatory path-
ways in mESC, we further characterized genes bound either individually or together by Msl1 and/or 
Nsl1. Out of 10,600 Msl1- and Nsl1-bound genes about one quarter are co-bound by both complexes, 
while 3274 are only bound by Msl1 and 2185 only by Nsl1 (Figure 5A, Figure 2—source data 2). Our 
statistical analyses showed that these numbers are significant (Figure 5—figure supplement 1). To 
identify genes regulated specifically by MSL and/or by NSL, we analysed genes bound by only Msl1, 
by only Nsl1, or together by Msl1 and Nsl1 for gene ontology (GO). All three categories are enriched 
for GO terms such as metabolic process, gene expression, cell proliferation, and cell cycle. These 
GO terms represent housekeeping functions of every cell type, but can also be related to the cellular 
homeostasis of ESCs. Interestingly, genes bound by only Msl1 are enriched for GO terms such as 
embryo development, stem cell differentiation and maintenance (Figure 5B). Importantly, almost 50% 
of all reference genes associated with stem cell maintenance are Msl1 positive (Figure 5B).
Therefore, we investigated the presence of Msl1 (and Nsl1) at mESC-specific genes. Available RNA-
seq data of mESCs (Tippmann et al., 2012) allowed us to define 282 genes expressed only in pluripo-
tent mESCs. Out of these 282 mESC-specific genes, 123 (44%) are bound by Msl1 and only 40 (14%) 
are Nsl1 positive. Furthermore, about 100 mESC-specific genes are bound exclusively by Msl1, while 
16 genes are bound only by Nsl1 (Figure 5C). Our statistical analyses indicate that only MSL binding 
at mESC-specific genes is higher than random (Figure 5—figure supplement 2).
To validate these bioinformatics analyses, all Msl1- and/or Nsl1-bound genes were divided into 
three categories (Figures 2B and 5A): Msl1- and Nsl1-bound genes (category 1), genes bound only by 
Nsl1 (category 2) and genes bound only by Msl1 (category 3). Msl1 and Nsl1 binding to the three gene 
categories were validated by ChIP-qPCR on a few selected genes. In agreement with all our above 
analyses, we observed that Msl1 binds to TSSs and/or GB regions of most genes from category 1 and 3 
(Figure 5D), whereas Nsl1 is detected mostly at the TSSs of genes from category 1 and 2 (Figure 5E). 
Our results also show that Msl1 positive genes contain several mESC specific genes, including genes 
related to the core pluripotency network (e.g., Oct4, Nanog and Sox2) (Figure 5E). In summary, we 
demonstrate that the two Mof-containing complexes bind to shared, MSL-, or NSL-specific gene sets, 
but only the MSL complex is present at genes regulating the ESC pluripotency network and develop-
mental processes.
NSL influences cellular proliferation of mESCs
In mouse embryos ablation of Mof results in lethality at embryonic day 3.5 and Mof also affects 
mESCs pluripotency (Gupta et al., 2008; Thomas et al., 2008; Li et al., 2012). To further analyse 
the cellular roles of MSL and NSL in mESCs, Msl1, or Nsl1 were individually depleted by shRNA KD 
(see Figure 2—figure supplement 2A–D). To exclude compensation between MSL and NSL com-
plexes, a double KD of Msl1 and Nsl1 (shMsl1/shNsl1) was also carried out (Figure 6—figure supple-
ment 1A). Next, total cell numbers were counted over 6 days. These analyses indicated that KD of 
Msl1 reduces slightly cell proliferation, while the KD of Nsl1, or the double KD of Msl1 and Nsl1 lead 
to a much slower cell growth (Figure 6A). When analysing cell morphology under these KD conditions, 
we did not observe any change in mESC shape. (Figure 6B) As the reduction of cell numbers under 
the KD conditions was not due to apoptosis (Figure 6—figure supplement 1B), we next carried out 
cell cycle analyses. These FACS measurements demonstrated that mESCs treated with shMSL1, shNsl1 
and shMsl1/shNsl1 accumulate in the G1-phase of the cell cycle, with shNsl1 and shMsl1/shNsl1 being 
more severe than shMsl1 (Figure 6C). These results together suggest that Nsl1 might be more required 
for regulating housekeeping genes involved in cellular homeostasis of mESCs, as reflected in higher 
number of G1-phase cells and decreased cell proliferation of shNsl1 and shMsl1/Nsl1 mESCs.
MSL binds to pluripotency genes regulated by Mof
To better understand the function of genes bound by MSL and NSL in mESCs, genome-wide expres-
sion changes were analysed by microarrays. To this end total RNA was isolated from control mESCs, 
or mESCs depleted for either Msl1, or Nsl1 (Figure 2—figure supplement 2A–D). In shMsl1 KD 
cells, 275 genes were found to be downregulated (with Msl1 itself is in the downregulated list 
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(Figure 7—source data 1)), and 500 genes upregulated, as compared to control KDs. By comparing 
Msl1-bound and Msl1-regulated genes (Figure 7A), we found that Msl1 is present at about 30% 
(105 genes) of all downregulated and at 20% (107 genes) of all upregulated genes. In Nsl1 KD condi-
tions, 1158 genes are downregulated (including Nsl1 itself) and 429 are upregulated, as compared to 
KD controls (Figure 7—source data 1). By comparing the genome-wide binding (ChIP-seq) and 
expression data changes following KD, we show that Nsl1 is present at 43% (441 genes) of all 
Figure 5. MSL and NSL bind to shared and specific gene sets. (A) Venn Diagram showing the overlap between Msl1 and Nsl1 binding sites at ENSEMBL 
genes. For statistical analyses see Figure 5—figure supplement 1A–C. Binding at TSSs and gene bodies was considered together. Genes are listed in 
Figure 2—source data 2. (B) Gene ontology analysis using Manteia (Tassy and Pourquie, 2013) of only Msl1 binding sites, only Nsl1 binding sites, or 
common binding sites. Significant GO terms for only Msl1 binding sites are highlighted by a box. (C) Differentially expressed genes were identified with 
the DEseq analysis (Anders and Huber, 2010). The table represents genes expressed only in mESCs (when compared to NPCs). The overlap with all 
Msl1 positive, all Nsl1 positive or only complex specific genes was calculated. Statistical analyses in Figure 5—figure supplement 2A–D indicates 
significant enrichment of Msl1 at mESC-specific genes. (D and E) Bound genes were divided into three categories: Common (category 1), specific for 
Nsl1 (category 2) and specific for Msl1 (category 3). From these categories genes were chosen for ChIP-qPCR using the anti-Msl1 (D) or anti-Nsl1 (E) 
antibodies. Fold enrichment higher than five was defined as specific binding and Msl1 and Nsl1 presence was analysed at the indicated genes in each 
category. Bar charts represent the mean and standard deviation of 2–3 independent experiments.
DOI: 10.7554/eLife.02104.012
The following figure supplements are available for figure 5:
Figure supplement 1. MSL and NSL significantly bind to shared and specific gene sets. 
DOI: 10.7554/eLife.02104.013
Figure supplement 2. MSL, but not NSL locates to mESC-specific genes. 
DOI: 10.7554/eLife.02104.014
Developmental biology and stem cells | Genes and chromosomes
Ravens et al. eLife 2014;3:e02104. DOI: 10.7554/eLife.02104 11 of 23
Research article
Figure 6. NSL influences cell growth and cell cycle of mESCs. (A) Cell proliferation analyses by cell counting over  
6 days of control, or indicated KD mESCs. Error bars represent the standard deviation of three independent 
experiments. See Figure 6—figure supplement 1A for validation of KD efficiency of sh Msl1/Nsl1 double KD 
mESCs. (B) Morphology of control and Msl1 and Nsl1 single or double KD mESCs at 6 days after lentiviral infection 
using a reverse-phase microscope with a 10x magnification. (C) Cell cycle analyses of control and KD mESCs by 
propidium iodide staining followed by FACS analyses. Cell numbers of G1-, S- or G2-phases are represented  
in percentages after analyses with CellQuest Pro software. See Figure 6—figure supplement 1B for apoptosis 
analysis.
DOI: 10.7554/eLife.02104.015
The following figure supplements are available for figure 6:
Figure supplement 1. shMsl1, shNsl1 and double KD mESCs do not undergo apoptosis. 
DOI: 10.7554/eLife.02104.016
downregulated and at 5% (30 genes) of all upregulated genes (Figure 7B). The Msl1-, or Nsl1-KD 
affected genes determined by the microarray analyses were then confirmed by RT-qPCR under Msl1-, 
or Nsl1-KD conditions (Figure 7C,D). Interestingly, we noticed genes known to be involved in differ-
entiation, like Nestin and Ntrk1, in the upregulated genes of shMsl1 mESCs (Figure 7C).
Altogether, our results show that the bound genes of which the expression is affected following 
either Msl1 or Nsl1 KD are those genes, which absolutely require either MSL or NSL for their correct 
regulation. Note however, that the relatively weak overlap between Msl1- and/or Nsl1-bound genes 
on one side and Msl1- and/or Nsl1-regulated genes on the other, may reflect that either the KDs 
were not sufficiently efficient, and/or that the global gene expression analysis detected only 
changes in the steady state levels of the mature mRNAs and not the changes in the neosynthesized 
pre-mRNAs. Along these lines, in our experimental system Msl1, or Nsl1 single, or double KD mESCs 
do not loose Oct4 expression (Figure 7—figure supplement 1A), a common marker of mESC 
pluripotency.
Since MSL and NSL are transcriptional co-activators, we were interested in the biological function 
of downregulated genes upon KD of either Msl1 or Nsl1. We also included available expression data 
from Mof knock-out (KO) mESCs (Li et al., 2012) to overcome the above-described limitations. 
Analysing the biological function of Msl1, Nsl1, or Mof downregulated genes, we observed GO terms 
like metabolic processes, gene expression, cell death, or cell cycle control (Figure 7—figure supple-
ment 1B). However, only downregulated genes in Mof KO mESCs are significantly enriched for GO 
terms like stem cell differentiation or maintenance (Figure 7E). Several of these genes are amongst the 
Msl1 positive mESC-specific genes, such as Nanog, Sox2, Oct4 (Li et al., 2012) (Figure 7F). Moreover, 
these genes are bound by Msl1 and Mof (Figure 7—figure supplement 2). Thus, the Mof-regulation 
and the exclusive binding of Msl1 and Mof to these key pluripotency genes suggest that the MSL 
complex is a regulator of the pluripotency network in mESCs.
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Figure 7. Analysis of Msl1 and Nsl1 regulated genes in mESCs. (A and B) Venn Diagram of Msl1 (A) or Nsl1 (B) MACS14 binding sites at ENSEMBL genes 
and down- or upregulated genes in Msl1 or Nsl1 KD cells. Down- and upregulated genes are listed in Figure 7—source data 1. For validation of KD 
efficiencies see Figure 2—figure supplement 2A–D. (C and D) RT-qPCR validation of down- and up-regulated genes in sh Msl1 (C) or sh Nsl1 (D) mESCs. 
(E) GO analyses using Manteia (Tassy and Pourquie, 2013) of all downregulated genes in Msl1 KD, Nsl1 KD and Mof KO mESCs. See Figure 7—figure 
supplement 1 for further GO analyses. (F) Gene expression changes in Mof KO vs wild-type mESCs according to Li et al. (2012) of genes involved in 
stem cell maintenance, represented as fold change.
DOI: 10.7554/eLife.02104.017
The following source data and figure supplements are available for figure 7:
Source data 1. Down- and upregulated genes in shMsl1 and shNsl1 mESCs. 
DOI: 10.7554/eLife.02104.018
Figure supplement 1. Msl1, Nsl1 and Mof regulate mESC-unspecific genes. 
DOI: 10.7554/eLife.02104.019
Figure supplement 2. Msl1 and Mof binding at pluripotency genes. 
DOI: 10.7554/eLife.02104.020
MSL binds to bivalent genes in mESCs
Our above analyses have shown that Msl1 binds not only to mESC-specific genes, but that it locates 
also to silent, or very weakly expressed, genes that become expressed to control mESC differentiation 
(Figure 8A, Figure 8—figure supplement 1A). Importantly, KD of Msl1 leads to the upregulation of 
developmental genes, such as Nestin and Ntrk1 (Figure 7C). These genes often contain both positive 
(H3K4me3) and negative (H3K27me3) epigenetic modifications (Figure 8A, Figure 8—figure supple-
ment 1A). It is well established that H3K4me3 and H3K27me3 histone modifications co-localize at 
bivalent domains, which are poised for a quick activation during distinct differentiation processes 
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Figure 8. MSL regulates mESC differentiation. (A) Msl1 binding together with Nsl1, H3K4me3, H3K27me3 and Pol II 
at the Nestin locus in mESCs. For the Hes5 gene locus see Figure 8—figure supplement 1A. (B) Heatmap 
showing k-means clustering of Msl1, Nsl1, Pol II, H3K4me3, Ezh2 and H3K27me3 using all Msl1 and Nsl1 binding 
sites as reference coordinates. Densities are presented −/+2 kb around reference coordinates. Based on the density 
profiles of all data sets, the heatmap is divided into different categories (as indicated). For statistical analyses of 
Msl1 positive bivalent genes in Cluster C see Figure 8—figure supplement 1B. (C and D) mRNA expression 
measurements by RT-qPCR of bivalent genes, which are also key markers for NPC differentiation, under sh control 
Figure 8. Continued on next page
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(Azuara et al., 2006; Bernstein et al., 2006). The Ezh2 subunit of the polycomb repressive complex 
2 (PRC2), which catalyzes histone H3K27 tri-methylation, is also a good marker of bivalent domains 
(Bernstein et al., 2006; Ku et al., 2008). To determine whether Msl1, or Nsl1, would bind to bivalent 
domains genome-wide, we compared the combined list of all Msl1 and Nsl1 binding sites with Pol II 
and Ezh2 profiles, together with H3K4me3 and H3K27me3 marks (Figure 8B). The heatmap indicates 
that about 343 Msl1 binding sites significantly co-localize with Ezh2, H3K27me3, and H3K4me3, which 
define the bivalent domains (see Cluster C in Figure 8B, Figure 8—figure supplement 1B for statis-
tical analyses). Importantly, these 343 bivalent domain sites are negative for Nsl1 binding. The pres-
ence of Msl1 (our study) and Mof (Li et al., 2012) at bivalent genes in mESCs suggests that the 
MSL complex is involved in keeping these developmental genes silenced, but poised for activation 
in mESCs.
MSL is required for gene regulation during mESC differentiation
As MSL, but not NSL, was found to be required for keeping bivalent genes silent or low expressed in 
pluripotent mESCs, we asked whether MSL could regulate bivalent gene expression during mESCs 
differentiation. For this, mESCs were differentiated into neuronal progenitor cells (NPCs) under control 
and Msl1 KD conditions (Figure 8—figure supplement 1C). Bivalent genes such as Pax6, Hes5, Mapt2 
and Nestin, which are also considered as key markers of NPC differentiation, were upregulated in 
pluripotent mESC under Msl1 KD conditions (Figure 8C; and see above). In contrary, but in agreement 
of the regulatory role of the MSL complex at these genes, these key developmental marker genes 
were downregulated in NPCs in which Msl1 was silenced by shRNA expression during NPC differenti-
ation (Figure 8D). Note however, that Msl1 KD cells morphologically are still able to form NPC-like 
cells (Figure 8—figure supplement 1D). These results together indicate the important regulatory 
requirement of the MSL complex first for keeping the subset of bivalent genes poised for activation in 
mESCs and then for turning them on during mESC differentiation.
Discussion
The composition and the genome-wide binding pattern of the MSL and 
NSL HAT complexes is conserved between mouse ESCs and other 
metazoan cells
In this study, we analysed two Mof-containing complexes, MSL and NSL to understand their transcrip-
tion regulation function in mESCs. The proteomic characterization of the mMsl1-, or mNsl1-containing 
complexes indicated that the subunit composition of the mMSL and the mNSL complexes is identical 
to human complexes (Figure 1C and see Mendjan et al., 2006; Cai et al., 2010). Importantly, the 
comparison of the abundance of Msl1 or Nsl1 with Mof in the respective complexes (Figure 1C) and 
our gel filtration analyses (Figure 1D) demonstrated the incorporation of Msl1 and Nsl1 together with 
Mof in their respective endogenous complexes. Moreover, the gel filtration experiment indicated the 
potential existence of ‘free’ Mof that may not be present in either MSL or NSL. Together, the prote-
omic analyses suggest that there is no free Msl1 or Nsl1 in the nuclei of mESCs and that Msl1 and Nsl1 
are specific to the MSL and NSL complexes, respectively.
This observation is important for our study as it indicates that the ChIP binding profiles obtained 
with either anti-Msl1 or anti-Nsl1 antibodies represent the behaviour of the corresponding endoge-
nous Mof-containing MSL, or NSL HAT complexes. Furthermore, our findings are consistent with pre-
vious observations, which suggested that Msl1 and Nsl1 directly interact with Mof in their respective 
complexes, to stabilize the assembly of these complexes and to regulate their HAT activity (Raja et al., 
2010; Kadlec et al., 2011).
(dark grey) and sh Msl1 conditions (light grey) in pluripotent mESCs (C) or in mNPCs (D) NPC formation and KD 
efficiency of Msl1 in NPCs was validated in Figure 8—figure supplement 1C,D.
DOI: 10.7554/eLife.02104.021
The following figure supplements are available for figure 8:
Figure supplement 1. MSL binds to bivalent genes. 
DOI: 10.7554/eLife.02104.022
Figure 8. Continued
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Similarly to Drosophila (Prestel et al., 2010; Raja et al., 2010; Kadlec et al., 2011; Feller et al., 
2012; Lam et al., 2012), our results demonstrate that mouse MSL and NSL have mainly distinct 
binding profiles at transcribed genes in mESCs. NSL binding overlaps with Pol II binding and DHSs 
at TSSs, while MSL locates more downstream of promoters towards the GB (Figure 2). These evolu-
tionary conserved binding profiles further suggest that the function of the MSL and NSL complexes 
in transcriptional regulation are also conserved between Drosophila and vertebrate cells.
MSL is the main H4K16 HAT in mESC
Surprisingly, in mESCs the KD of Msl1, but not that of Nsl1, leads to a global loss of H4K16ac, without 
reducing H4K5ac and H4K8ac levels (Figure 4D). In differentiated human cells Mof, and subunits of 
MSL (i.e. Msl1, Msl3) or the Nsl1 subunit of NSL have been reported to be crucial for global H4K16 
acetylation by either MSL or NSL, respectively (Li et al., 2009; Zhao et al., 2013). Thus, while the 
subunit composition of the two Mof-containing MSL and NSL complexes is conserved between mESCs 
and differentiated human cells (Figure 1C; Cai et al., 2010), the function of the NSL complex seems 
to be differently regulated in pluripotent mESCs than in differentiated cells. Our observation that 
the KD of the Nsl1 subunit of NSL does not abolish global H4K16ac levels in mESCs suggests that 
in these pluripotent cells NSL may have a very localized HAT activity around TSSs of bound genes 
and the acetylation at these loci cannot be detected in total histone preparations, in contrary to the 
Msl1 KD. This difference may also be due to the more dynamic recruitment of NSL by mESC-specific 
factors. In contrast to MSL, NSL binding to promoters does not correlate with RNA expression levels 
(Figure 3B–D). This further suggests that the two Mof-containing complexes have different mecha-
nisms of action in transcriptional regulation in mESCs. Moreover, the depletion of MSL function is 
supposed to recapitulate those chromatin perturbations and related cellular changes that are caused 
by the Mof KO and are linked to H4K16ac loss.
Strikingly, the gene expression of only a small number of MSL or NSL bound genes was directly 
affected when either Msl1 or Nsl1 was depleted (Figure 7A,B). This might be due to either inefficient 
KDs, or the measurement of steady-state mature mRNA levels under our experimental conditions. As 
contrary to Msl1 and Nsl1, ‘free’ Mof was detected in mESC nuclear extracts (Figure 1D), we cannot 
exclude the possibility that to certain extent Mof alone could compensate for the function of the MSL 
or NSL complex under Nsl1 and Msl1 KD conditions. However, the abolished global H4K16ac levels in 
shMsl1 mESCs would rather propose that other transcriptional co-activators, modifying other histone 
residues than H4K16, could compensate the role of H4K16ac in transcriptional activation.
In summary, our data demonstrating that MSL is the main HAT complex responsible for global 
H4K16ac in mESCs (Figure 4D), together with the finding that genome-wide binding profiles of Msl1 
and Mof overlap with H4K16ac, (Figure 2D) suggest that the co-activator role of MSL is linked to its 
H4K16 acetylation function at the bound genes.
MSL and NSL have different functions in pluripotent mESCs
The transitions between distinct chromatin states, from the open acetylated chromatin of the pluripo-
tent mESCs to the more compact deacetylated chromatin of the differentiated cells, suggest the 
requirement for a tightly regulated chromatin acetylating/deactylating balance that participates in 
defining pluripotency on one hand and the consequent commitments for distinct differentiation path-
ways on the other hand. The HAT Mof is important for mESC pluripotency. Mof-deficient embryos 
have slight cell cycle defects and undergo cell death (Thomas et al., 2008). Under our experimental 
conditions, KD of Msl1 and Nsl1 alone or together did not affect expression of key transcription factors 
of the pluripotency network (Figures 6A, Figure 7). Our observation that in mESCs Nsl1 KD leads to 
decreased cell numbers during proliferation and an increase in cells in the G1-phase of the cell cycle 
shows that NSL might influence mESC proliferation (Figure 6B–D). This further indicates that NSL 
might be required for the homeostasis of mESC, either by directly regulating transcription or through 
acetylation of non-histone targets.
H4K16ac was shown to promote chromatin fibre decompaction in vitro (Shogren-Knaak et al., 
2006; Robinson et al., 2008; Allahverdi et al., 2011). Our data showing that Msl1 KD abolishes 
global H4K16ac levels, together with the aberrant chromatin compaction observed in the Mof-deficient 
embryos (Thomas et al., 2008), suggest that the MSL complex is an important factor in establishing 
high acetylation levels required for more open chromatin conformation and consequent mESC pluri-
potency. In addition to its role as a general regulator of H4K16ac in mESCs, the MSL complex seems 
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to be recruited to ESC-specific loci to regulate different steps in the transcription process, such as (i) 
chromatin accessibility, (ii) pre-initiation complex formation and/or (iii) Pol II transcription elongation 
rates. Importantly, the Msl1-bound mESC-specific genes are regulated by Mof. Note however, these 
Mof- and Msl1-bound and Mof-regulated genes were not affected by the KD of Msl1 (Figure 5B–D, 
Figure 7E,F). As above explained this may be due to the different experimental systems used here and 
the Mof KO study. Nevertheless, we assume that these genes are regulated by the whole MSL com-
plex. Altogether, the exclusive co-binding of Msl1 and Mof to pluripotency genes suggests that the 
MSL complex is a regulator of the pluripotency network in mESCs.
MSL is required at bivalent genes to silence them in pluripotent ESCs 
and to upregulate them during ESCs differentiation
Bivalent genes, which are either repressed or expressed at very low levels in mESCs can be directly 
upregulated or completely silenced upon differentiation (Azuara et al., 2006; Bernstein et al., 2006). 
So far, little is known about the function of HATs at bivalent genes. Interestingly, we show that a subset 
of bivalent genes (about 350 genes) is bound by MSL in ESCs (Figure 8A,B, Figure 8—figure supple-
ment 1A) and consequently that the KD of Msl1 results in the upregulation of a subset of bivalent 
genes in mESCs (Figure 8C). Consistent with our study, Mof has also been shown to be present at 
bivalent genes (Li et al., 2012). It seems that the MSL complex, probably in concert with HDACs 
and/or other chromatin remodelling factors, can have a silencing function at these bivalent genes. In 
contrast, the same genes require MSL for expression during differentiation (Figure 8D). Even though 
the morphology of NPCs was not obviously influenced under Msl1 KD conditions, expression of key 
developmental NPC genes, such as Pax6 and Hes5, were downregulated during NPC differentiation 
(Figure 8D). Thus, our findings together with the observation that Mof is also binding to bivalent 
genes in mESCs, strongly suggests that the presence of MSL at bivalent loci is important for keeping 
these bivalent genes poised in pluripotent mESCs, allowing a quick transcriptional upregulation of 
the same genes during mESC differentiation.
Summary
In summary, MSL and NSL are key transcriptional co-activators at a large number of expressed genes 
in mESCs, whereas each complex has a distinct binding profile either at promoters (NSL) or gene 
bodies (MSL). MSL and NSL have overlapping and distinct roles in transcriptional regulation in mESCs. 
NSL binds mostly to genes with housekeeping functions and mediates mESC proliferation suggesting 
that NSL is important for the cellular homeostasis of mESCs. MSL is the main acetyltransferase com-
plex acetylating H4K16. Moreover, MSL binds to mESC-specific genes, which are de-regulated in Mof 
ablated mESCs. Moreover MSL is present at bivalent domains in mESCs, where it may poise genes for 
activation during mESC differentiation. Importantly, expression of those genes is directly regulated by 
MSL in differentiated NPCs. In the future, it will be interesting to investigate how the genome-wide 
function of MSL and NSL changes during distinct mESC differentiation pathways.
Materials and methods
Cell culture
Wild-type male mESCs (E14.wt) were cultivated on 0.1% gelatine (Sigma, France) and CD1 feeder 
cells (37°C, 5% CO2) in DMEM (4.5 g/l glucose) w-Glutamax-I, 15% foetal calf serum ESC-tested, 
leukemia inhibiting factor (5 μg) (Sigma), 50 mM ß-Mercaptoethanol (Invitrogen, France), penicillin/
streptomycin (Invitrogen), 200 mM L-glutamine (Invitrogen), and non-essential amino acids (GIBCO, 
France). To work under feeder-free conditions cells were treated with 1 mg/ml Collagenase (GIBCO) 
and 2 mg/ml Dispase (GIBCO) and cultivated for one passage without feeder cells on 0.1% gelatine 
(Sigma) coated plates. Experiments were conducted at passage 26–29. Mouse embryonic fibroblasts 
(3T3 ATCC) were cultivated in DMEM (4.5 g/l glucose), 10% newborn calf serum and gentamycin 
(Invitrogen).
For NPC generation, we followed the protocol of Bibel et al. (2007). Briefly, 6 × 106 mESC were 
cultured in DMEM (4.5 g/l glucose) w-Glutamax-I, 10% foetal calf serum ESC-tested, 50 mM ß-Mercap-
toethanol (Invitrogen), penicillin/streptomycin (Invitrogen), 200 mM L-glutamine (Invitrogen), and non-
essential amino acids on bacteriological Petri dishes (37°C, 5% CO2) to start differentiation. After 
4 days retinoic acid (5 μm) (Sigma) was added to induce NPC formation. Experiments were conducted 
8 days after differentiation.
Developmental biology and stem cells | Genes and chromosomes
Ravens et al. eLife 2014;3:e02104. DOI: 10.7554/eLife.02104 17 of 23
Research article
Generation of antibodies
Polyclonal anti-Msl1 (3208) and anti-Nsl1 (3130) antibodies were generated by immunization of rabbits 
with the N-terminal (3-210 amino acids) region of mouse Msl1 or C-terminal region (762-1037 amino 
acids) of mouse Nsl1. The fragment was amplified and cloned in pET28b (Novagen, France) vector to 
express proteins in E. coli (BL21). For primer sequences see Supplementary file 1. Polyclonal antibod-
ies were purified through Affi-Gel columns (Bio-Rad). For WB analysis anti-Msl1 (3208) or anti-Nsl1 
(3130) antibodies were diluted 1:2000.
Preparation of ESC nuclear extracts and immunoprecipitation
Nuclear extracts were prepared from 30 P15 plates of mESCs with 80% confluency as described in 
Demeny et al. (2007). Proteins of 3 mg (Msl1) or 1 mg (Nsl1) mESC nuclear extracts were immunoprecipi-
tated (IP) with 100 μl protein A Sepharose beads and 20 μl of the anti-Msl1 (3208) or 20 μl of the anti-Nsl1 
(3130) antibody. Antibody-protein A Sepharose containing the bound proteins were washed three times 
with IP buffer (25 mM Tris-HCl pH 7.9, 10% glycerol, 0.1% NP40, 0.5 mM DTT, 5 mM MgCl2) and 100 mM 
KCl and afterwards with IP buffer containing 250 mM KCl. Proteins were eluted from protein A Sepharose 
beads 150 μl of 0.1 M Glycine pH 2.6. Elutions were neutralized by adding 50 μl of 2 M Tris pH 8.5.
MudPIT analysis
MudPIT analyses were performed as previously described (Washburn et al., 2001; Florens et al., 
2006). In summary, protein mixtures were TCA precipitated, urea-denaturated, reduced, alkylated, 
and digested with endoproteinase Lys-C (Roche) followed by modified trypsin digestion (Promega). 
Peptide mixtures were loaded onto a triphasic 100 μm diameter fused silica microcapillary column 
described as follows (McDonald and Yates, 2002). Loaded microcapillary columns were placed in-line 
with a Quaternary Dionex Ultimate 3000 HPLC pump and a LTQ Velos linear ion trap mass spectrom-
eter equipped with a nano-LC electrospray ionization source (ThermoFischerScientific). A fully auto-
mated 12-steps MudPIT run was performed as previously described (Florens et al., 2006) during 
which each full MS scan (from 300 to 1700 m/z range) was followed by 20 MS/MS events using data-
dependent acquisition. Proteins were identified by database searching using SEQUEST (Eng et al., 
1994) within ThermoProteome Discoverer 1.3 and 1.4 (ThermoFischerScientific). Tandem mass spectra 
were searched against a Mus musculus protein sequence database containing 16,604 entries (from the 
Swissprot 2013-04-03 release). In all searches, cysteine residues were considered to be fully carboxy-
amidomethylated (+57 Da statically added) and methionine considered to be oxidized (+16 Da 
dynamically added). Proteins were considered as specific in a given IP data set if they were absent or 
10-fold minimum enriched as compared to a MOCK IP, performed on the same protein input by using 
a non-specific antibody targeting yeast TAF90. Relative protein abundance for each protein in either 
the anti-Msl1, or the anti-Nsl1 IPs was estimated by the calculation of a Normalized Spectral Abundance 
Factor (NSAF) (Zybailov et al., 2006). NSAF values were calculated from the spectral counts of each 
identified protein. To account for the fact that following enzymatic digestion larger proteins result 
in more peptides/spectras than small proteins, each given spectral count was divided by the corre-
sponding protein length to provide a spectral abundance factor (SAF). To obtain NSAF, SAF values 
were normalized against the sum of all SAF values in the corresponding run. Thus, NSAF values 
obtained from a given protein mixture, such as immunoprecipitated protein complexes, allow the 
comparison of the abundance of a given protein/subunit to another in the same mixture/complex.
Gel filtration
For gel filtration a Superose 6 (10/300) column pre-equilibrated in 25 mM Tris pH 7.9, 1 mM DTT, 5 mM 
MgCl2, 150 mM KCl, and 5% Glycerol was used. 250 μl calibration mix containing Dextran Blue (2 MDa) 
and Biorad calibration kit (ref 151-1901) with marker sizes of 670 kDa, 158 kDa, 44 kDa, 17 kDa, and 
1.35 kDa were injected at 0.3 μl/min. 500 μl of mESC nuclear extract containing 1 mg protein was 
injected and run at 0.3 μl/min. 40 fractions were collected and analysed by western blot. For western 
blot the anti-Mof (A300-992a; Bethyl) antibody was used.
Chromatin immunoprecipitation
ChIP was carried out as described previously with slight modifications (Krebs et al., 2011). At 80% con-
fluency mESCs were cross-linked with 1% formaldehyde for 10 min at room temperature, lysed and 
shared mechanically using the Covaris E210 to obtain a chromatin fragment size of 200–500 bp. IP were 
carried out using 500 μg of chromatin. For the IP 3 μg of purified Msl1 3208 or Nsl1 3130 antibodies were 
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used. The input was obtained from 50 μg of chromatin, pre-cleared, and directly reverse crosslinked. 
DNA was purified using a Qiaquick (Qiagen, France) column. Quantitative real-time PCR (qPCR) was 
performed with SYBR Green (Roche). Primer sequences are summarized in the Supplementary file 1.
ChIP-seq
10 ng of precipitated DNA obtained from ChIP was used for Solexa sequencing. To create a genomic 
library, we followed the instructions of NEXTFlex v12.03 (BIO Scientific) for Msl1 and the NEBNext 
protocol (E6240; Biolabs) for Nsl1. Libraries were validated with the Agilent Bioanalyzer. Single reads 
run sequencing was conducted with the HiSeq 2000. Image analysis and base calling were done 
with the Illumina pipeline (1.8.2). The July 2007 Mus musculus genome assembly (NCBI37/mm9) from 
NCBI was used for the sequence alignment by the software Bowtie (0.12.7) (Langmead, 2010). All 
analyses were conducted with unique reads. Bed files were used to create read density (wig) files by 
extending reads to 200 bp length and creating 25 bp bins. We further included following sequencing 
datasets, which were obtained from Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) in our 
analysis: Input (GSM798320) (Karmodiya et al., 2012), RNA Polymerase II (GSM307623), H3K4me3 
(GSM307618), H3K27me3 (GSM307619), Ezh2 (GSM327668) (Mikkelsen et al., 2007), H4K16ac 
(GSM1156617) (Taylor et al., 2013), and Mof (GSM915227) (Li et al., 2012). Fastq files were gener-
ated from SRA lite format and aligned to the NCBI37/mm9 assembly using Bowtie (0.12.7) (Langmead, 
2010). DHS were obtained from Encode/UW (GSM1014154).
Peak detection and annotation
To detect Msl1 and Nsl1 peaks, the algorithm MACS14 (Zhang et al., 2008) was applied using default 
parameters with slight modifications. For Msl1 peak detection the p-value cutoff was set to 10−5, no 
shifting model was built and the shift size was defined as 200. The annotation was based on the ENSEMBL 
67 database (mm9). Peaks were annotated to genomic features (TSS, TTS, CDS Exons, 5'UTR, 3′UTR, 
Introns and intergenic) using the software HOMER (4.2) (Heinz et al., 2010) with default parameters.
Data analysis
To calculate the Msl1, Nsl1, or Pol II enrichment at a given gene either the peak tag density of the 
nearest peak to the TSS (in a region of +2 kb), was obtained through MACS14 (Zhang et al., 2008) or 
the total tag density around the TSS (+2 kb) was taken. Further analysis and graphical representation 
were conducted using the software R.
Density profiles around the TSS and GB were obtained through seqMINER (Ye et al., 2011). For the 
comparison and analysis of genomic features between data sets, the software BEDTools (2.17.0) (Quinlan 
and Hall, 2010) was used. Scatter plots and Pearson correlations with Pearson p-values were obtained 
by calculating the log2 values of read densities normalized to the control at the given peaks or around 
ENSEMBL transcription start sites. K-means linear clustering was conducted and represented with 
seqMINER. Venn diagrams were generated with Biovenn (Hulsen et al., 2008). Manteia (v.2) was used 
for GO analysis of batch gene entries to understand the biological function (Tassy and Pourquie, 
2013). Only GO levels between 1 and 10 were taken into consideration and compared between groups.
Bootstrap statistical analysis
To verify the statistical significance of the obtained Msl1- or Nsl1-bound gene groups in Figure 5A,C 
and Figure 8B, we performed bootstrap statistical analyzes for Figure 5A,C and Figure 8B. In all these 
analyses, we used the total pool of 26,460 ENSEMBL genes. Next out of these pools, we randomly 
selected the same number of total events (genes or binding sites) than those determined non-
randomly in the corresponding figures (i.e., 10600 in Figure 5A; 282 in Figure 5C and 13,505 in 
Figure 8). This random selection was then compared with the different given interest gene lists 
(i.e. 3274, 2570, and 2185 for Figure 5A) and the number of genes (IDs) belonging to the non-
random experimental group was determined. We repeated this process of random selection and 
gene list crossings 10,000 times and represented the number of IDs and their observed frequencies as 
histograms (see corresponding figure supplements). For each gene list, we computed an average 
(mean) and a standard deviation (sd) of the number of random matches. A z-score is computed as: 
z = (mean-expect)/sd, where 'expect' is the number of expected interest genes. p-values associated 
to these scores are indicated in the corresponding figure legends. On each histogram we indicated in 
bold the number of IDs found in the non-random experimental group. The p-value represents the 
significance of the difference between the randomly found average and the experimental ID numbers.
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RNA-seq
Gene expression levels are based on the ENSEMBL 67 database (mm9). Raw data of mESCs and NPCs 
were taken from Gene Expression Omnibus (GSE34473) and processed using the software tools 
TopHat (Trapnell et al., 2009) and HTSeq with default parameters. FPKM (fragments per kilobase of 
exon per million fragments mapped) values were calculated with Cufflinks (Roberts et al., 2011). 
Differentially expressed genes (DE) in mESCs and NPCs were identified with the bioconductor package 
DESeq (1.14.0) (Anders and Huber, 2010) using default parameters.
shRNA interference
shRNA approaches were conducted with pLKO.1 puro shRNA vectors (Sigma–Aldrich, France) of the 
TRC2 library. For Ns1 KD the TRCN0000241466 shRNA clone and for Msl1 KD the TRCN0000241378 
shRNA clone was used. Double KD of Msl1 and Nsl1 was conducted with equal amount of the 
TRCN0000241466 and TRCN0000241378 shRNA clones. For control the shRNA non-target control 
(Product No. SHC002) was applied. Production of lentiviral particles as well as infection of mESCs was 
conducted according to the manufacturer's protocol. 3 days after viral transfection of 2 × 106 mESCs 
selection with puromycin (2 μg /ml) (InvivoGen) was started. Experiments were conducted 5 days 
after viral transfection. KD efficiency was tested at RNA levels through reverse transcriptase (RT)-qPCR 
(see Supplementary File 1) and at protein levels through western blot of whole protein extracts. 
Moreover, mRNA expression of selected genes was analysed by (RT)-qPCR, whereas primer sequences 
are summarized in Supplementary file 1. Total RNA, which was used for gene expression profiles 
and cDNA synthesis, was isolated with TRIzol reagent (Invitrogen) and treated with DNAse. cDNA 
was synthesized with Transcriptor reverse transcriptase (Roche) using random hexamers according to 
the manufacturer's protocol. For normalization of protein amount by WB analyses the anti-Tubulin 
(T6557; Sigma-Aldrich) antibody and ponceau solution (Sigma-Aldrich) was applied. To analyse the 
pluripotency state of KD mESCs the anti-Oct4 (611202; BD Labs) antibody was used. To analyse cell 
morphology images were taken with the digital inverted EVOS XL core (Fisher Scientific, France) 
microscope using a 10X objective.
Isolation of mESC total histones and western blot assay
Histones were prepared from mESCs by lysing cells in 10 mM HEPES, pH 7.5, 1.5 mM MgCl2, 10 mM 
KCl, 0.5 mM DTT, 100 mM Natrium Butyrate, and 0.2 M HCl for 30 min on ice, centrifuged and dia-
lysed first against 0.1 M acidic acid and then against water. Samples were analysed by western blot for 
histone modifications using the anti-H4K16ac (07-329; Millipore, France), anti-H4K5ac (51997; Abcam, 
UK), anti-H4K8ac (15823; Abcam), and anti-H3 (1791; Abcam) antibody.
Cell growth analysis
Cell growth analyses was started 6 days after lentiviral infection by plating 1 × 105 mESCs on 0.1% 
gelatine coated per 6-well plates in triplicates. mESCs were counted in triplicates using Neubauer 
cell counting chambers at indicated time points. mESCs were split every second day to 1 × 105 
mESCs/6-well.
Cell cycle analysis
7 days after lentiviral infection 5 × 105 mESCs were dissolved in 1 ml PBS (0.1% NaCitrate and 0.1% 
TritonX 100). Propidium iodide (50 μg/ml) was added and after 4 hr incubation on ice cells were ana-
lysed by the FACS calibur. Data were analysed using the CellQuest software.
Cell death assay
Cell death was examined using the APOPercentage apoptosis assay (A1000/DC79; Biocolor, France) 
following the manufacturer's instructions. As a positive control apoptosis was induced with 10 mM 
hydrogen peroxide for 8 hr in sh control cells. Absorbance was read at 550 nm and normalized to the 
blank control (without cells).
Gene expression profiles and statistics
Experiments were designed with three independent biological replicas. Biotinylated cDNA targets 
were prepared, starting from 150 ng of total RNA, using the Ambion WT Expression Kit (Cat 4411974), 
and the Affymetrix GeneChip WT Terminal Labelling Kit (Cat 900671) according to Affymetrix recom-
mendations. Following fragmentation and end-labeling, 3 μg of cDNAs were hybridized on GeneChip 
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Mouse Gene 2.0 ST arrays (Affymetrix, UK) for whole-transcript expression profiles. Washed and 
stained chips were scanned with the GeneChip Scanner 3000 7 G (Affymetrix) at a resolution of 0.7 μm. 
Obtained raw data (.CEL intensity files) were processed with Affymetrix Expression Console software 
version 1.1 to calculate probe set signal intensities using Robust Multi-array Average (RMA) algorithms 
with default settings.
To select the DE genes, we used the fold change rank ordering statistics (FCROS) method 
(Dembele and Kastner, 2014). In the FCROS method, k pairs of test/control samples are used to 
compute fold changes (FC). For each pair of test/control samples, obtained FCs for all genes are 
ranked in increasing order. Ranks that result are associated to genes. Then, the k-ranks of each gene 
are used to calculate a statistic, and resulting probability (f-value) is used to identify the DE genes 
with an error level of 5%.
Accession numbers
Msl1 and Nsl1 ChIP-seq data sets as well as gene expression profiles of sh control, sh Msl1 and sh Nsl1 
mESCs are deposited at Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under the accession 
numbers: GSE53797 and GSE56646.
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